Results 181 to 190 of about 94,073 (238)

A Case of Myeloproliferative Neoplasm with Eosinophilia Associated with PCM1-JAK2 Rearrangement. [PDF]

Case Rep Oncol
Zhou W, Guo X, Liu Y, Hao Z, Chu S, Zhang L, Li L.   +6 more
europepmc   +1 more source

[Myeloproliferative neoplasm with a homozygous germline SH2B3 mutation: a case report and literature review]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang W, Li R, Tian J, Jiang LJ, Bai J, Gu YH, Wang YY, Su Y, Li YQ, Xue YM, Chen JM, Wei YP.   +11 more
europepmc   +1 more source

ZRSR2 loss causes aberrant splicing in JAK2^V617F-driven myeloproliferative neoplasm but is not sufficient to drive disease progression. [PDF]

Hemasphere
Zhang R, Straube J, Janardhanan Y, Haldar R, Cooper L, Hayes N, Laurore C, Kim CJ, Luskin MR, Lindsley RC, Stahl M, Mullally A, Marneth AE, Bywater M, Lane SW.   +14 more
europepmc   +1 more source

Unraveling the impact of lysosomal dysfunction on myeloproliferative neoplasm. [PDF]

Cancer Med
Yoon H, Lee D, Song S, Koo B, Park J, Kim TK, Kim S, Kim S, Hong J, Byun JM, Shin DY, Kim I, Koh Y, Yoon SS.   +13 more
europepmc   +1 more source

Autophagosome-lysosome mediated secretion of the thrombopoietin receptor is modulated by distinct driver mutations of myeloproliferative neoplasm. [PDF]

Leukemia
Chowdhury S, Shrivastva S, Singh A, Ansari F, Naseer S, Roy A.   +5 more
europepmc   +1 more source

Arachidonic acid promotes myeloid differentiation of splenic CD45- Ter119+ cells in myeloproliferative neoplasm. [PDF]

J Cancer
Zhang L, Yang Y, Yu X, Li G, Zhang P, Ren X, Luo S, Li L, Munyurangabo G, Jia Y, Song L, He A, Kong G.   +12 more
europepmc   +1 more source

Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts. [PDF]

Front Oncol
Wang Y, Jin S.
europepmc   +1 more source

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study. [PDF]

Br J Haematol
Batyrbekova N, Hultcrantz M, Ravn Landtblom A, Szulkin R, Dickman PW, Andersson TM, Syriopoulou E.   +6 more
europepmc   +1 more source

TP53-Mutated Acute Myeloid Leukemia and Blast Phase Myeloproliferative Neoplasm: Distinct Mutation Leads to Poorer Prognosis. [PDF]

Eur J Haematol
Chen D, Cantu M, Siddon A, Weinberg OK.
europepmc   +1 more source

Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm. [PDF]

Curr Oncol Rep
Singh S, Peshin S, Larsen A, Gowin K.
europepmc   +1 more source